2',3',5'-Triacetyluridine
| Title | Journal |
|---|---|
| A rational approach to the regioselective deacetylation of 2',3',5'-tri-O-acetyluridine by Novozym 435 catalysed alcoholysis. | Biochimica et biophysica acta 20120401 |
| Use of uridine triacetate for the management of fluorouracil overdose. | American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists 20111001 |
| Enhanced uridine bioavailability following administration of a triacetyluridine-rich nutritional supplement. | PloS one 20110101 |
| Triacetyluridine (TAU) decreases depressive symptoms and increases brain pH in bipolar patients. | Experimental and clinical psychopharmacology 20080601 |
| Phthalocyanine-based molecularly imprinted polymers as nucleoside receptors. | Metal-based drugs 20080101 |
| Oral uridine pro-drug PN401 is neuroprotective in the R6/2 and N171-82Q mouse models of Huntington's disease. | Neurobiology of disease 20061201 |
| Phase II trial of PN401, 5-FU, and leucovorin in unresectable or metastatic adenocarcinoma of the stomach: a Southwest Oncology Group study. | Investigational new drugs 20061101 |
| 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice. | Cancer chemotherapy and pharmacology 20060701 |
| Continued survival of more than ten years, without resection of metastatic disease, in patients with metastatic colorectal cancer treated with biomodulated fluorouracil: report of two cases. | Diseases of the colon and rectum 20060301 |
| Severe cytochrome c oxidase inhibition in vivo does not induce a pyrimidine deficiency; neuroprotective action of oral uridine prodrug PN401 requires supraphysiological levels of uridine. | Brain research 20051220 |
| Neuroprotective effects of oral administration of triacetyluridine against MPTP neurotoxicity. | Neuromolecular medicine 20040101 |
| Oral uridine pro-drug PN401 decreases neurodegeneration, behavioral impairment, weight loss and mortality in the 3-nitropropionic acid mitochondrial toxin model of Huntington's disease. | Brain research 20031219 |
| Synthesis and hypnotic activities of 4-thio analogues of N3-substituted uridines. | Chemical & pharmaceutical bulletin 20010901 |